Background Up to 30% of children with acute asthma are refractory to initial therapy, and
84% of this subpopulation needs hospitalization. Finding safe, noninvasive, and effective …

Background Intravenous magnesium sulfate, a rescue therapy added to bronchodilator and
systemic steroid therapy for moderate and severe asthma, is uncommonly administered. We …

Importance While intravenous magnesium decreases hospitalizations in refractory pediatric
acute asthma, it is variably used because of invasiveness and safety concerns. The benefit …

Background Asthma is the most common pediatric chronic disease and currently affects 7.1
million children in the United States. Many children experience acute asthma exacerbations …

Objective To examine the use, efficacy, and safety of intravenous magnesium sulfate (IVMg)
in children with asthma whose emergency department (ED) management is recorded in the …

This systematic review and meta-analysis aimed to evaluate the efficacy of intravenous (IV)
and nebulized magnesium sulfate for acute asthma in children. Ten randomized and quasi …

BACKGROUND Use of intravenous magnesium (IVMg) for childhood asthma exacerbations
has increased significantly in the last decade. Emergency department administration of IVMg …

Background There is limited knowledge regarding whether intravenous magnesium (IV-Mg)
improves outcomes in children with acute asthma exacerbations. Objective To examine …

Objective This study aimed to evaluate the efficacy of intravenous (IV) and nebulized
magnesium sulfate in acute asthma in children. Methods The PubMed, Cochrane Library …

Importance Despite guidelines recommending administration of intravenous (IV) magnesium
sulfate for refractory pediatric asthma, the number of asthma-related hospitalizations has …